PEB, RYM- 2 healthcare stocks in news as Taupō’s Vaccine pass rules ease

March 14, 2022 04:42 PM NZDT

Be the First to Comment

Jasmine Anand

Author

Jasmine Anand - Financial Journalist
832 Posts
Jasmine Anand is a Financial Journalist at Kalkine. She has an extensive experience of 11 years in varied domains like finance, E-commerce, content curation, product research, education and telecom. She has earned a Master in Business Administr...
Follow
Shaghil Bilali

Editor

Shaghil Bilali - Research Editor
5 Posts
Shaghil Bilali is a research editor with 15 years of experience in different verticals across media. He has worked with some of the leading media organisations in India. Before joining Kalkine Media, he was with Microsoft News' Canada overnight opera...
Follow Shaghil Bilali Follow

More on: Pacific Edge Limited Ryman Healthcare Limited

Healthcare stocks — Image source: Monster Ztudio, Shutterstock.com

Highlights

Vaccine pass requirements are not mandatory in several of Taupō’s venues.

Pacific Edge get a new CEO from Boston.

Ryman Healthcare posts impressive HY22 performance.

Taupō’s District Council chief has announced a relaxation of My Vaccine Pass requirements across the district’s several venues and facilities from today onwards.

With the availability of children’s vaccines and high vaccination rates in the region, New Zealanders must learn to live with COVID-19 in the community, cites the District chief.

Some of the venues which no longer require vaccine passes for entry include Taupō Museum, AC Baths swimming pools, Great Lake Centre as well as Taupō District libraries.

However, Taupō Events Centre and function rooms continue to have vaccine passport requirements owing to capacity numbers, etc.

That said, let us look at the two popular NZX-listed healthcare stocks that can be considered.

Pacific Edge Limited (NZX:PEB; ASX:PEB)

Pacific Edge Limited is a leading name in the cancer diagnostic market, specialising in diagnostic and prognostic tests for better cancer detection and management. A few days ago, the Company had announced its new CEO, Dr Peter Meintjes, who has relocated from Boston to New Zealand and will work from the company’s Dunedin-based Head Office.

Do Must: PEB and GFL: 2 NZX penny stocks making strides today

Peter has vast experience in molecular diagnostics, especially in the US region.

At the time of writing, on 14 March, PEB was down by 2.22% at NZ$0.880.

Ryman Healthcare Limited (NZX:RYM)

Ryman Healthcare Limited is New Zealand’s famous operator of retirement villages. Sometime back, the Company released its HY22 report, highlighting an 8.5% growth in its unaudited underlying profit, amounting to NZ$95.9 million, owing to strong demand for its retirement living and aged care options.

Must Read: RYM, OCA- 2 NZX retirement village stocks amid COVID-19 surge in NZ

It has solid long-term growth plans and has commenced construction work across its new sites.

Moreover, in December 2021, RYM had distributed 8.8 cps as an interim dividend.

At the time of writing, on 14 March, RYM was trading flat at NZ$9.500.

Bottom Line

NZ boasts a robust healthcare sector, offering world-class products and services to its residents.